Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
CC

Christopher R. Cornell — 4 Patents

BTBioelectron Technology: 2 patents #7 of 14Top 50%
EPEdison Pharmaceuticals: 1 patents #16 of 24Top 70%
PTPtc Therapeutics: 1 patents #120 of 160Top 75%
Mountain View, CA: #4,399 of 11,022 inventorsTop 40%
California: #126,026 of 386,348 inventorsTop 35%
Overall (All Time): #1,080,739 of 4,157,543Top 30%
4 Patents All Time
Christopher R. Cornell has been granted 4 US patents while listed as an inventor at Bioelectron Technology. The first was granted in 2014 and the most recent in March 2024. Christopher R. Cornell ranks #1,080,739 of 4,157,543 US inventors in our database (top 26.0%). Patent records list Christopher R. Cornell in Mountain View, CA, US.

Patents per Year

Patents granted per year, 2014 to 2024Bar chart with a peak of 2 patents in 2019.peak 22014: 1 patents20142019: 2 patents20192024: 1 patents2024

Issued Patents All Time

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11938101 Polymorphic forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide Paul Mollard, Peter Giannousis, Shazad Suchit, Mahmoud Mirmehrabi, Kieron E. Wesson 2024-03-26 $33,437,000
10251847 Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide Paul Mollard, Kieron E. Wesson, Peter Giannousis, Shazad Suchit, Mahmoud Mirmehrabi 2019-04-09
10189830 Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stress disorders Andrew W. Hinman, Kieron E. Wesson 2019-01-29
8716527 2-substituted-p-quinone derivatives for treatment of oxidative stress diseases Andrew W. Hinman, Kieron E. Wesson, Orion D. Jankowski, Paul Mollard, William D. Shrader 2014-05-06